- Home
- VLCN vs XXII Comparison
VLCN vs XXII Comparison
Compare VLCN & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLCN
- XXII
- Stock Information
- Founded
- VLCN 2020
- XXII 1998
- Country
- VLCN United States
- XXII United States
- Employees
- VLCN N/A
- XXII N/A
- Industry
- VLCN Auto Manufacturing
- XXII Medicinal Chemicals and Botanical Products
- Sector
- VLCN Consumer Discretionary
- XXII Health Care
- Exchange
- VLCN Nasdaq
- XXII Nasdaq
- Market Cap
- VLCN N/A
- XXII 2.8M
- IPO Year
- VLCN 2021
- XXII N/A
- Fundamental
- Price
- VLCN $0.85
- XXII $1.30
- Analyst Decision
- VLCN
- XXII
- Analyst Count
- VLCN 0
- XXII 0
- Target Price
- VLCN N/A
- XXII N/A
- AVG Volume (30 Days)
- VLCN 321.4K
- XXII 52.8K
- Earning Date
- VLCN 05-06-2025
- XXII 03-20-2025
- Dividend Yield
- VLCN N/A
- XXII N/A
- EPS Growth
- VLCN N/A
- XXII N/A
- EPS
- VLCN N/A
- XXII N/A
- Revenue
- VLCN $4,037,191.00
- XXII $24,382,000.00
- Revenue This Year
- VLCN N/A
- XXII $45.16
- Revenue Next Year
- VLCN N/A
- XXII $48.70
- P/E Ratio
- VLCN N/A
- XXII N/A
- Revenue Growth
- VLCN 23.80
- XXII N/A
- 52 Week Low
- VLCN $0.66
- XXII $1.24
- 52 Week High
- VLCN $384.00
- XXII $581.85
- Technical
- Relative Strength Index (RSI)
- VLCN 34.87
- XXII 27.85
- Support Level
- VLCN $0.81
- XXII $1.32
- Resistance Level
- VLCN $1.07
- XXII $1.51
- Average True Range (ATR)
- VLCN 0.09
- XXII 0.15
- MACD
- VLCN 0.05
- XXII 0.05
- Stochastic Oscillator
- VLCN 17.74
- XXII 8.45
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.